Pancreatic Cancer Research

ResearcherLeiden UniversityActive in the last 2 years

Erik H.J. Danen

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-0491-6345; OpenAlex author ID A5037747325. Sources: OpenAlex.

Their work

Papers
9 (first author 1, last author 2)
Trials
0
Grants
0
Labs led
1
Collaborators
19
Papers, trials and grants by year

2017: 1 paper · 2018: none · 2019: none · 2020: 1 paper · 2021: 1 paper · 2022: 1 paper · 2023: 1 paper · 2024: 4 papers

Papers 9

  1. Differential Sensitivity to Ionizing Radiation in Gemcitabine-Resistant and Paclitaxel-Resistant Pancreatic Cancer Cells. Co-author DOI 10.1016/j.ijrobp.2023.10.035↗
  2. ABCB1 overexpression through locus amplification represents an actionable target to combat paclitaxel resistance in pancreatic cancer cells. Last author DOI 10.1186/s13046-023-02879-8↗
  3. Targeting ABC transporters in PDAC - past, present, or future? Last author DOI 10.18632/oncotarget.28597↗
  4. Altered Mechanobiology of PDAC Cells with Acquired Chemoresistance to Gemcitabine and Paclitaxel. Co-author DOI 10.3390/cancers16223863↗
  5. Prognostic Significance of Integrin Subunit Alpha 2 (ITGA2) and Role of Mechanical Cues in Resistance to Gemcitabine in Pancreatic Ductal Adenocarcinoma (PDAC). Co-author DOI 10.3390/cancers15030628↗
  6. Therapy-Naive and Radioresistant 3-Dimensional Pancreatic Cancer Cell Cultures Are Effectively Radiosensitized by β1 Integrin Targeting. First author DOI 10.1016/j.ijrobp.2021.08.035↗
  7. Correction: Görte et al. Comparative Proton and Photon Irradiation Combined with Pharmacological Inhibitors in 3D Pancreatic Cancer Cultures. Cancers 2020, 12,… Co-author DOI 10.3390/cancers13133364↗
  8. Comparative Proton and Photon Irradiation Combined with Pharmacological Inhibitors in 3D Pancreatic Cancer Cultures. Co-author DOI 10.3390/cancers12113216↗
  9. A mechanopharmacology approach to overcome chemoresistance in pancreatic cancer. Co-author DOI 10.1016/j.drup.2017.07.001↗

Closest collaborators

The 19 strongest of 19 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Elisa Giovannetti · 6 shared papers, 2017–2024 · strength 1.20
  2. Cecilia Bergonzini · 5 shared papers, 2023–2024 · strength 1.13
  3. Thomas Schmidt · 5 shared papers, 2017–2024 · strength 0.84
  4. Alessandro Gregori · 4 shared papers, 2023–2024 · strength 0.76
  5. Josephine Görte · 3 shared papers, 2020–2022 · strength 0.61
  6. Nils Cordes · 3 shared papers, 2020–2022 · strength 0.61
  7. Mjriam Capula · 3 shared papers, 2023–2024 · strength 0.58
  8. Liam Andrew McDonnell · 2 shared papers, 2024 · strength 0.36
  9. Pei Pei · 1 shared paper, 2024 · strength 0.18
  10. Adam Enver Frampton · 1 shared paper, 2024 · strength 0.18
  11. Asia Botto · 1 shared paper, 2024 · strength 0.18
  12. Ingrid Garajová · 1 shared paper, 2024 · strength 0.18
  13. Annalisa Comandatore · 1 shared paper, 2023 · strength 0.16
  14. Fatemeh Khojasteh‐Leylakoohi · 1 shared paper, 2023 · strength 0.16
  15. Luca Morelli · 1 shared paper, 2023 · strength 0.16
  16. Amir Avan · 1 shared paper, 2023 · strength 0.16
  17. Ilaria Carnevale · 1 shared paper, 2017 · strength 0.08
  18. Stefano Coppola · 1 shared paper, 2017 · strength 0.08
  19. Godefridus J. Peters · 1 shared paper, 2017 · strength 0.08

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.